Ranbaxy plunges over 4% on supreme court notice - The New Indian Express

Ranbaxy plunges over 4% on supreme court notice

Published: 14th March 2014 04:19 PM

Last Updated: 14th March 2014 04:19 PM

Ranbaxy Laboratories, one of the leading pharma players, plunged on Friday after media reports said that the Supreme Courtissued a notice the government and the company on a public-interest litigation seeking a CBI probe against the company for allegedly supplying adulterated drugs in the country. Shares ofthe companyare trading at Rs 340.15, down Rs 14.8, or 4.17% at the Bombay Stock Exchange (BSE) on Friday at 2:10 p.m.The scrip has touched an intra-day high of Rs 353.00 and low of Rs 335. The total volume of shares traded at the BSE is 576,348.In the earlier session, the shares fell 2.22%, or Rs 8.05, at Rs 354.95. Currently, the stock is trading down 30.6% from its 52-week high of Rs 490.15 and above 33.94% over the 52-week low of Rs 253.95.

comments powered by Disqus

Disclaimer: We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the NIE editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.


Read More



follow us Mobile Site iPad News Hunt Android RSS Tumblr Linekin Pinterest Youtube Google Plus Twitter Facebook